
MNKTQ
Healthcare · Drug Manufacturers - Specialty & Generic · $1.1M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 9, 2023 | Before the open | — | -56.65 | — |
| May 3, 2022 | Time not confirmed | — | -1.42 | — |
| Mar 15, 2022 | Time not confirmed | — | -2.41 | — |
| Nov 2, 2021 | Time not confirmed | — | -3.18 | — |
| Aug 3, 2021 | Time not confirmed | — | -1.25 | — |
| May 4, 2021 | Time not confirmed | — | -1.70 | — |
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology,…